Deutsche Bank
TEVA icon

Deutsche Bank’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Deutsche Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,867
Closed -$107K – 5893
2014
Q4 		$107K Sell
1,867
-103
-5% -$5.74K ﹤0.01% 4685
2014
Q3 		$105K Buy
1,970
+1,321
+204% +$70K ﹤0.01% 4474
2014
Q2 		$34K Sell
649
-145,352
-100% -$7.43M ﹤0.01% 5110
2014
Q1 		$20K Buy
146,001
+136,346
+1,412% +$6.3M ﹤0.01% 4842
2013
Q4 		$9K Buy
+9,655
New +$380K ﹤0.01% 4919

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Deutsche Bank's TEVA Position: Q2 2026 in Review

Deutsche Bank increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 7.3% in Q2 2026, buying an estimated $6.9M and bringing the position to 3,037,225 shares worth $103M. The position accounts for 0.03% of the portfolio, ranked #497.

Deutsche Bank first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $193M in Q2 2015. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Deutsche Bank held 3,037,225 shares of Teva Pharmaceutical Industries Limited worth $103M as of Q2 2026.
  • Deutsche Bank bought 207,255 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $6.9M.
  • Teva Pharmaceutical Industries Limited made up 0.03% of Deutsche Bank's portfolio in Q2 2026, its #497 holding.
  • Deutsche Bank first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Teva Pharmaceutical Industries Limited position peaked at $193M in Q2 2015.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.